StockData
Cellebrite DI Ltd. logo

Cellebrite DI Ltd. (CLBT) stock

CLBTNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 3, 2026Score 13/30
$11.12−0.41 (-3.56%)

Close on Nov 16, 2026Market cap $2.77BP/E 35.9Yield –

Cellebrite DI r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $113.88M, up 15.7% from the year before. The highest annual figure on record is $113.88M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$113.88M+15.7%
FY2024Dec 31, 2024$98.42M+16.6%
FY2023Dec 31, 2023$84.39M+4.7%
FY2022Dec 31, 2022$80.62M+23.0%
FY2021Dec 31, 2021$65.54M+20.5%
FY2020Dec 31, 2020$54.38M+16.8%
FY2019Dec 31, 2019$46.57M–

More Cellebrite DI figures

See a number that looks wrong?